In part 4 of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the regulation of supplements and the potential dangers of some products.
Read More »Yearly Archives: 2018
Laura Shane-McWhorter Part 5, References for Nutritional Products
In part 5, the conclusion of this Exclusive Interview, Laura Shane-McWhorter talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the possibilities of creating a supplement product and the references that can help health care providers to ferret out the best products to recommend.
Read More »Programs Can Lower Diabetes Distress in Adults With T1DM
Both education/behavioral and emotion-focused approaches produce similar results
Read More »Obesity Paradox Seen in T2DM Modified by Smoking Status
Obesity paradox was pronounced in current smokers, and absent in never smokers
Read More »July 7, 2018
This week, we have another jam-packed newsletter with the latest from the ADA Scientific Sessions in Orlando. There are some great articles on the use of CGM and insulin delivery systems both alone and in concert with each other. There is a look at a new system that uses AI …
Read More »New Closed-Loop Delivery System Improves Glycemic Control for People with T1D
Multi-center study compares closed-loop device to standard open-loop system in a home setting.
Read More »Metformin Alone or Combined with Insulin Does Not Improve or Preserve Beta-Cell Function in T2D
Restoring Insulin Secretion (RISE) Pediatric Medication Study shows that youth have markedly reduced insulin sensitivity and respond differently to medications.
Read More »Intense Multifactorial Treatment for Type 2 Diabetes Shown to be Cost Effective: Steno 2 Study
Analysis of European Steno 2 study examines long-term economic implications of interventions targeting complications.
Read More »New Omnipod® Closed-Loop Insulin Delivery System Improves Glycemic Control
Hybrid closed-loop (HCL) system combines technology of CGM and insulin pumps, and a personalized, model-predictive control algorithm to deliver insulin day and night.
Read More »Liraglutide Plus Insulin for People with Type 1 Diabetes Improves Glycemic Control
One-year, randomized study shows lower HbA1c, blood glucose, blood pressure and body weight without significant increase in hypoglycemia.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.